Show
Sort by
-
Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH)
-
- Journal Article
- A1
- open access
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
-
- Journal Article
- A2
- open access
Retroperitoneal liposarcoma : current insights in diagnosis and treatment
-
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
-
MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance
-
- Journal Article
- A2
- open access
Selective inhibition of the p53–MDM2 interaction by nutlin drugs: a new therapeutic perspective for neuroblastoma
-
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
-
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
-
A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma
-
New options for molecular therapy of neuroblastoma: from p53 to gene therapy
(2011)